Your browser doesn't support javascript.
loading
Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes.
Gordon, Ryan R; Wu, Mengchu; Huang, Chung-Ying; Harris, William P; Sim, Hong Gee; Lucas, Jared M; Coleman, Ilsa; Higano, Celestia S; Gulati, Roman; True, Lawrence D; Vessella, Robert; Lange, Paul H; Garzotto, Mark; Beer, Tomasz M; Nelson, Peter S.
Afiliação
  • Gordon RR; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Wu M; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Huang CY; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Harris WP; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Sim HG; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Lucas JM; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Coleman I; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Higano CS; Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America.
  • Gulati R; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • True LD; Department of Pathology, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America.
  • Vessella R; Department of Urology, University of Washington, Seattle, Washington, United States of America.
  • Lange PH; Department of Urology, University of Washington, Seattle, Washington, United States of America.
  • Garzotto M; Department of Urology and Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, United States of America; Section of Urology, Portland VA Medical Center, Portland, Oregon, United States of America.
  • Beer TM; Department of Medicine, Oregon Health and Sciences University, Portland, Oregon, United States of America.
  • Nelson PS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Pathology, University of Washington, Seattle, Washin
PLoS One ; 9(9): e104271, 2014.
Article em En | MEDLINE | ID: mdl-25198178
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Resistência a Medicamentos / Protocolos de Quimioterapia Combinada Antineoplásica / Regulação Enzimológica da Expressão Gênica / Regulação Neoplásica da Expressão Gênica / Monoaminoxidase / Proteínas de Neoplasias Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Resistência a Medicamentos / Protocolos de Quimioterapia Combinada Antineoplásica / Regulação Enzimológica da Expressão Gênica / Regulação Neoplásica da Expressão Gênica / Monoaminoxidase / Proteínas de Neoplasias Idioma: En Ano de publicação: 2014 Tipo de documento: Article